Isatin, its 5-chloro and 5-bromo derivatives have beer) reacted with 4-(4-chloropheny1)-6-(4-nietl~ylpI~e1~yl)-2-i11~1i1iopyri1~lidi1e to fortn Scliif'f bases and the N-Mannich bases of these compounds were syrlthesized by reacting thern with folmaldehyde and several seconda~y arnines. The cornpoullds were evaluated in vitro against Mycobacterium ~~ih~~t+c~lrlo.si.s L137Rv at 6.25 pdml in BACTEC 12l3 tnediunl using the BACTEC 460 radiometric system. A~r~o n g the cotnpounds tested 3-14-(4-ch1orophenyl)-6-(4-methylphenyl) pyrimidin-2-yllirninoisatin (Sl) showed prornising activity with 97% inhibition at a concentration of 6.25 pglrnl.
I. Introduction
Tuberculosis is making a worldwide resurgence. Several factors may be responsible for the increase in cases rates, including infection with human immunodeficiency virus, cl~angi~ig economic and social circu~nstances and decline in tuberculosis control programs'. In addition, outbreaks of multi-drug resistant tuberculosis have been identified2. Wllen the AIDS pandetnic began, one third of the world population was infected with Mycobacrerium tzrberczrlosis. Each year, eight to ten million persons developed active disease and three million persons died fro~n tuberculosis. Currently available first-line antituberculous agents, such as rifampicin, isoniazid, etharnbutol, streptomycin and pyrazinamide are highly effective and generally well tolerated.
Problelns in the clie~notlierapy of tuberculosis asise when patients develop bacterial resistance to any of these first-line drugs and because second-line drugs such as paminosalicylic acid, amikacin, cycloserine, capreomycin and ethlonamide are less effective and Inore toxic! The infuriating truth is t l~t tlie pl~arnaceutical industry has produced nothing in the way of new tuberculosis drugs since rifampicin was introduced in the 1960s, even though rifapentine, a long-acting rifamycin drug was more rece~itly investigated by Hoecl~st Marion Roussel. In the course of screening to discover new coinpounds e~nployed in the chemotherapy of tuberculosis, we identified some Isatin derivatives, which inhibited in-vim Mycobactenam tuberculosis H37 R~.
Thus taking into account our experience in the field of the synthesis of new Isatin derivatives5-'", we present results concerning the sylithesis of isatin derivatives bearing pyrimidine nucleus and the in-viiro antituberculous activity of the first representative compounds of this family. 
I)iscussion
All the syntl~rsized con~pounds tested in preliminary screening at 6.25 ~r n l showed percentage of illhibition ranging from 86 to 97%. The compound S1 emerged as highly active analogue in this series with 97% inhibition and the MIC determintion are still under study at TAACF. USA. This cornpourid (Sl) was found to be equipotent with Gentarnycin, as active as Doxycylirle Tobrarnycin and Clariihromycin against M.
rr~hcrc~tr/o.s~.s H37 Rv. I n general the Schiff bases (Sl, S5, S9) were more active than
Manriicli bases and with regard to the substitutents at the 5th position, the order of activity was foutid to be H > Bt. > CI. Among the Mannicl~ bases the order of activity was as dirnethylamirio > piperiditlo > morpholino derivatives. From a preliminary examination of these results, it appears that compound S1 showed potent activity against hi. ~lrbcrc~lr/o.sr.s l-137 Rv. Tiiese results need to be refined in telms of minimum inhibitory concerltratiorl and toxicity. Further studies to acquire more information about the structure-activity relationships are in progress in our laboratories. 4 . Experin~ental
I . Chemical Proccdurcs
Melting points were determined on a Thomas-Hoover melting point apparatus and are uncorrected. IR spcct~.il were I-ecorded on a Jasco infrared spectrolneter in KBr. 'H-NMR spectra were recorded on a JeoI Fx 90Q FT-NMR spectrometer (90MHz) employing tetra~nethylsilane as the internal reference, Elemental analyses were undertaken for all the compounds and were within 0.4% of the calculated values. TLC was carried on silica gel chromatograms.
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Synthesis of 4-(4-chlorophenyl)-6-(4-methylphenyl)-2-aminopyrimidine
(C3, t1270N5C12) C, H, N .
Similarly Other Matinich bases S2-S4, S6, S8 and S10-S12 were prepared by using appropriate Schiff bases with fo~maldehyde and corresponding secondary mines in tetrahydrofuran as a solvent.
Biological Evaluation

Antituberculous Screening
Antituberculous activity was determined using the BACTEC 460 stern'^-'^ as GI of test sample/ GI of control) x 100. MIC of rifampin was defined as the lowest concentratio11 of compound effecting a reduction in the daily change in GI which was less than that observed with a 1:100-diluted control culture on the day the latter reached a GI of atleast 30.
